Mitochondria, Ca2+ and neurodegenerative disease

European Journal of Pharmacology

Volumn 447, Issue 2-3, 2002, Pages 177-188

  Krieger, Charles ^a,b   Duchen, Michael R ^c  

^a SIMON FRASER UNIVERSITY   (Canada)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^c UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

Alzheimer's disease; Apoptosis; Ca2+; Glutamate; Mitochondrion; Motor neuron disease; Necrosis

Indexed keywords

AMINO ACID RECEPTOR; CALCIUM ION; CASPASE 7; CASPASE 9; CYTOCHROME C OXIDASE; HYDROGEN PEROXIDE; MITOCHONDRIAL DNA; MITOGEN ACTIVATED PROTEIN KINASE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; NITRIC OXIDE; PROTEIN KINASE C; PROTON TRANSPORTING ADENOSINE TRIPHOSPHATE SYNTHASE; PYRUVIC ACID; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE DEHYDROGENASE (UBIQUINONE); STAUROSPORINE; STRESS ACTIVATED PROTEIN KINASE; SUCCINATE DEHYDROGENASE (UBIQUINONE); SUPEROXIDE DISMUTASE; CALCIUM; FREE RADICAL; REACTIVE OXYGEN METABOLITE;

ALZHEIMER DISEASE; APOPTOSIS; CALCIUM SIGNALING; CALCIUM TRANSPORT; CELL DAMAGE; CELL DEATH; CELL FUNCTION; CITRIC ACID CYCLE; DEGENERATIVE DISEASE; DISEASE PREDISPOSITION; DISORDERS OF MITOCHONDRIAL FUNCTIONS; HUMAN; MITOCHONDRION; NONHUMAN; OXIDATION REDUCTION STATE; PARKINSON DISEASE; PATHOGENESIS; PRIORITY JOURNAL; REVIEW; ANIMAL; CELL MEMBRANE POTENTIAL; METABOLISM; OXIDATION REDUCTION REACTION; PHYSIOLOGY;

ANIMALS; CALCIUM; FREE RADICALS; HUMANS; MEMBRANE POTENTIALS; MITOCHONDRIA; NEURODEGENERATIVE DISEASES; OXIDATION-REDUCTION; REACTIVE OXYGEN SPECIES; RECEPTORS, N-METHYL-D-ASPARTATE; SUPEROXIDE DISMUTASE;

EID: 0037025256     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(02)01842-3     Document Type: Article

References (83)

1. Giant multilevel cation channels formed by Alzheimer's disease amyloid beta-protein [A-beta-P-(1-40)] in bilayer membranes
2. Regulation of mitochondrial iron accumulation by Yfh1p, a putative homologue of frataxin
3. Mitochondrial dysfunction in neurodegenerative diseases
4. Parvalbumin overexpression alters immune-mediated increases in intracellular calcium and delays disease onset in a transgenic model of familial amyotrophic lateral sclerosis
5. Early vacuolization and mitochondrial damage in motor neurons of FALS mice are not associated with apoptosis or with changes in cytochrome oxidase histochemical reactivity
6. Chronic systemic pesticide exposure reproduces features of Parkinson's disease
7. Identification of a ryanodine receptor in rat heart mitochondria
8. CXCR4-activated astrocyte glutamate release via TNFalpha: Amplification by microglia triggers neurotoxicity
9. 2+ waves in rat cortical astrocytes
10. Mitochondrial and extramitochondrial apoptotic signaling pathways in cerebrocortical neurons
11. 2+ overload and ROS generation in spinal motor neurons in vitro
12. Beta-amyloid inhibits integrated mitochondrial respiration and key enzyme activities
13. An evaluation of the role of mitochondria in neurodegerative diseases: Mitochondrial mutations and oxidative pathology, protective nuclear responses, and cell death in neurodegeneration
14. Oxidative stress, mitochondrial function and acute glutamate excitotoxicity in cultured cerebellar granule cells
15. Glutamate neurotoxicity and diseases of the nervous system
16. Cytochrome c oxidase subunit I microdeletion in a patient with motor neuron disease
17. Mitochondrial intermembrane junctional complexes and their role in cell death
18. Calretinin and calbindin D-28k delay the onset of cell death after excitotoxic stimulation in transfected P19 cells
19. Contributions of mitochondria to animal physiology: From homeostatic sensor to calcium signalling and cell death
20. Z+ in cell physiology and pathophysiology
21. Functional Imaging of Mitochondria within cells
22. Imaging mitochondria in intact cells
23. Mitochondrial production of reactive oxygen species in cortical neurons following exposure to NMDA
24. +: Implications for neurodegeneration
25. Inhibitors of protein kinase C prevent the toxicity of glutamate in primary neuronal cultures
26. Organelle-specific initiation of cell death pathways
27. Cyclosporin A, but not FK 506, protects mitochondria and neurons against hypoglycemic damage and implicates the mitochondrial permeability transition in cell death
28. Inhibition of ICE slows ALS in mice
29. Mitochondrial nitric-oxide synthase stimulation causes cytochrome c release from isolated mitochondria. Evidence for intramitochondrial peroxynitrite formation
30. Recruitment of the mitochondrial-dependent apoptotic pathway in amyotrophic lateral sclerosis
31. The mitochondrial permeability transition: Its molecular mechanism and role in repurfusion injury
32. Activation of protein kinase C by intracellular free calcium in the motoneuron cell line, NSC-19
33. Glia: Listening and talking to the synapse
34. Making mitochondrial mutants
35. What nourishes me, destroys me: Towards a new mitochondrial biology
36. Mitochondrial oxidative stress and cell death in astrocytes -requirement for stored Ca(2+) and sustained opening of the permeability transition pore
37. Regulation of mitochondrial ATP synthesis by calcium: Evidence for a long-term metabolic priming
38. Excitotoxic mitochondrial depolarisation requires both calcium and nitric oxide in rat hippocampal neurons
39. Brain cytochrome oxidase in Alzheimer's disease
40. Massive mitochondrial degeneration in motor neurons triggers the onset of amyotrophic lateral sclerosis in mice expressing a mutant SOD1
41. Bcl-2: Prolonging life in a transgenic mouse model of familial amyotrophic lateral sclerosis
42. NMDA-dependent superoxide production and neurotoxicity
43. Chronic parkinsonism in humans due to a potentent meperidine analog
44. The relationship between mitochondrial state, ATP hydrolysis, [Mg2+]I and [Ca2+]I studied in isolated rat cardiomyocytes
45. Cyclosporin A enhances survival, ameliorates brain damage, and prevents secondary mitochondrial dysfunction after a 30-minute period of transient cerebral ischemia
46. In CA1 pyramidal neurons of the hippocampus protein kinase C regulates calcium-dependent inactivation of NMDA receptors
47. How protein kinase C activation protects nerve cells from oxidative stress-induced cell death
48. Role of calcium ions in regulation of intramitochondrial metabolism
49. Chemiosmotic hypothesis of oxidative phosphorylation
50. Deficiencies in complex I subunits of the respiratory chain in Parkinson's disease
51. Glutamate toxicity in a neuronal cell line involves inhibition of cystine transport leading to oxidative stress
52. Cortical cytochrome oxidase activity is reduced in Alzheimer's disease
53. Mitochondrial dysfunction and neuromuscular disease
54. Calcium signaling in retinal glial cells and its effect on neuronal activity
55. Mitochondria and neuronal survival
56. Mitochondrial membrane potential and glutamate excitotoxicity: Mortality and millivolts
57. Abnormalities of the electron transport chain in idiopathic Parkinson's disease
58. Electron transport chain defects in Alzheimer's disease
59. Privileged access to mitochondria of calcium influx through NMDA receptors
60. Mitochondria as all-round players in the calcium game
61. Specific coupling of NMDA receptor activation to nitric acid neurotoxicity by PSD-95 protein
62. The "new" mitochondrial disorders
63. Mitochondrial complex I deficiency in Parkinson's disease
64. Oxidative glutamate toxicity can be a component of the excitotoxicity cascade
65. 2+ uptake into the endoplasmic reticulum and mitochondria
66. 2+ channels by glucose metabolism in mouse pancreatic beta-cells
67. Food toxins, ampa receptors and motor neuron diseases
68. G93A mutation of familial amyotrophic lateral sclerosis
69. The rotary mechanism of ATP synthase
70. Glutamate-induced neuron death requires mitochondrial calcium uptake
71. Classes of thiols that influence the skeletal muscle calcium release channel
72. Cybrids in Alzheimer's disease: A cellular model of the disease?
73. Triggering and execution of neuronal death in brain ischemia: Two phases of glutamate release by different mechanisms
74. Assessment of mitochondrial polarization status in living cells based on analysis of spatial heterogeneity of rhodamine 123 fluorescence staining
75. Source specificity of early calcium neurotoxicity in cultured embryonic spinal neurons
76. Calcium dynamics and buffering in oculomotor neurons from mouse that are particularly resistant during amyotrophic lateral sclerosis (ALS)-related motoneuron disease
77. Glutamate-induced mitochondrial depolarisation and perturbation of calcium homeostasis in cultured rat hippocampal neurones
78. Exploration of the role of reactive oxygen species in glutamate neurotoxicity in rat hippocampal neurons in culture
79. Mitochondrial DNA abnormalities in skeletal muscle of patients with sporadic amyotrophic lateral sclerosis
80. m-Dependent and -independent production of reactive oxygen species by rat brain mitochondria
81. Modulation of NMDA-mediated toxicity by protein kinase C
82. The prevention of the staurosporine-induced apoptosis by Bcl-X(L), but not by Bcl-2 or caspase inhibitors, allows the extensive differentiation of human neuroblastoma cells
83. Reactive oxygen species (ROS)-induced ROS release: A new phenomenon accompanying induction of the mitochondrial permeability transition in cardiac myocytes